# Pausing Antiretroviral Treatment Under Structured Evaluation

> **NCT06031272** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 32 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** 3BNC117-LS-J
- **DRUG:** 10-1074-LS-J
- **DRUG:** Placebo for 3BNC117-LS-J
- **DRUG:** Placebo for 10-1074-LS-J

## Key facts

- **NCT ID:** NCT06031272
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-28
- **Primary completion:** 2025-10-14
- **Final completion:** 2026-06-30
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06031272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06031272, "Pausing Antiretroviral Treatment Under Structured Evaluation". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06031272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*